首页 > 最新文献

Oftalmologicheskii zhurnal最新文献

英文 中文
Detecting diabetic retinopathy using an artificial intelligence-based software platform: a pilot study 利用人工智能软件平台检测糖尿病视网膜病变:一项试点研究
Q4 Medicine Pub Date : 2024-02-23 DOI: 10.31288/oftalmolzh202412731
A. Nevska, O. A. Pohosian, K. O. Goncharuk, D. F. Sofyna, O. O. Chernenko, K. M. Tronko, N. I. Kozhan, A. Korol
{"title":"Detecting diabetic retinopathy using an artificial intelligence-based software platform: a pilot study","authors":"A. Nevska, O. A. Pohosian, K. O. Goncharuk, D. F. Sofyna, O. O. Chernenko, K. M. Tronko, N. I. Kozhan, A. Korol","doi":"10.31288/oftalmolzh202412731","DOIUrl":"https://doi.org/10.31288/oftalmolzh202412731","url":null,"abstract":"","PeriodicalId":19419,"journal":{"name":"Oftalmologicheskii zhurnal","volume":"190 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140437788","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tear lactoferrin and ceruloplasmin levels in patients with traumatic and recurrent corneal erosions 外伤性和复发性角膜糜烂患者的泪液乳铁蛋白和脑磷脂水平
Q4 Medicine Pub Date : 2024-02-23 DOI: 10.31288/oftalmolzh20241814
I. Gavrylyak, Dmytro Zhaboiedov, N. Greben, Artem Tykhomyrov
level increased and the tear Cp level decreased to the levels in controls, and there was a negative correlation between the tear Lf level and the tear Cp level (r = -0.491, p < 0.001). Conclusion: The results confirmed the feasibility of utlizing Lf-containing eye drops as an adjunct in the treatment of TCE and RCE. This approach contributed to the restoration of ocular surface homeostasis, thus promoting corneal epithelialization and enabling a reduction in treatment duration.
与对照组相比,泪液 Lf 水平升高,泪液 Cp 水平降低,泪液 Lf 水平与泪液 Cp 水平呈负相关(r = -0.491,p < 0.001)。结论研究结果证实了使用含 Lf 的滴眼液辅助治疗 TCE 和 RCE 的可行性。这种方法有助于恢复眼表平衡,从而促进角膜上皮化,缩短治疗时间。
{"title":"Tear lactoferrin and ceruloplasmin levels in patients with traumatic and recurrent corneal erosions","authors":"I. Gavrylyak, Dmytro Zhaboiedov, N. Greben, Artem Tykhomyrov","doi":"10.31288/oftalmolzh20241814","DOIUrl":"https://doi.org/10.31288/oftalmolzh20241814","url":null,"abstract":"level increased and the tear Cp level decreased to the levels in controls, and there was a negative correlation between the tear Lf level and the tear Cp level (r = -0.491, p < 0.001). Conclusion: The results confirmed the feasibility of utlizing Lf-containing eye drops as an adjunct in the treatment of TCE and RCE. This approach contributed to the restoration of ocular surface homeostasis, thus promoting corneal epithelialization and enabling a reduction in treatment duration.","PeriodicalId":19419,"journal":{"name":"Oftalmologicheskii zhurnal","volume":"14 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140436834","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association of TLR4 rs1927911 polymorphism with diabetic retinopathy and diabetic macular edema in type 2 diabetic patients TLR4 rs1927911 多态性与 2 型糖尿病患者糖尿病视网膜病变和糖尿病黄斑水肿的关系
Q4 Medicine Pub Date : 2024-02-23 DOI: 10.31288/oftalmolzh202412026
S. Rykov, Ie. P. Galytska, D. V. Zhmuryk, V. A. Dufynets
{"title":"Association of TLR4 rs1927911 polymorphism with diabetic retinopathy and diabetic macular edema in type 2 diabetic patients","authors":"S. Rykov, Ie. P. Galytska, D. V. Zhmuryk, V. A. Dufynets","doi":"10.31288/oftalmolzh202412026","DOIUrl":"https://doi.org/10.31288/oftalmolzh202412026","url":null,"abstract":"","PeriodicalId":19419,"journal":{"name":"Oftalmologicheskii zhurnal","volume":"2 6","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140436993","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Changes in visual abnormalities after endonasal endoscopic surgery for giant pituitary adenoma with extension to the ventricular system 巨大垂体腺瘤扩展至脑室系统的鼻内镜手术后视觉异常的变化
Q4 Medicine Pub Date : 2024-02-23 DOI: 10.31288/oftalmolzh202416166
K. Iegorova, O.V. Ukrainets, Mykola O. Guk
{"title":"Changes in visual abnormalities after endonasal endoscopic surgery for giant pituitary adenoma with extension to the ventricular system","authors":"K. Iegorova, O.V. Ukrainets, Mykola O. Guk","doi":"10.31288/oftalmolzh202416166","DOIUrl":"https://doi.org/10.31288/oftalmolzh202416166","url":null,"abstract":"","PeriodicalId":19419,"journal":{"name":"Oftalmologicheskii zhurnal","volume":"33 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140435755","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retinal changes as evidenced by fundoscopy and their frequencies in patients with COVID-19 with different variants of the angiotensin-converting enzyme gene 眼底镜检查显示的视网膜变化及其在血管紧张素转换酶基因不同变体的 COVID-19 患者中的发生频率
Q4 Medicine Pub Date : 2024-02-23 DOI: 10.31288/oftalmolzh202415460
K. M. Hutsaliuk, Z. I. Rossokha, N. Skalska, N. Ulianova
{"title":"Retinal changes as evidenced by fundoscopy and their frequencies in patients with COVID-19 with different variants of the angiotensin-converting enzyme gene","authors":"K. M. Hutsaliuk, Z. I. Rossokha, N. Skalska, N. Ulianova","doi":"10.31288/oftalmolzh202415460","DOIUrl":"https://doi.org/10.31288/oftalmolzh202415460","url":null,"abstract":"","PeriodicalId":19419,"journal":{"name":"Oftalmologicheskii zhurnal","volume":"16 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140435355","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk factors for the progression of age-related macular degeneration in patients of the Ukrainian population 乌克兰人口中老年性黄斑变性进展的风险因素
Q4 Medicine Pub Date : 2024-02-23 DOI: 10.31288/oftalmolzh202413743
Sergiy Mogilevskyy, Tetiana Zavgorodnia
{"title":"Risk factors for the progression of age-related macular degeneration in patients of the Ukrainian population","authors":"Sergiy Mogilevskyy, Tetiana Zavgorodnia","doi":"10.31288/oftalmolzh202413743","DOIUrl":"https://doi.org/10.31288/oftalmolzh202413743","url":null,"abstract":"","PeriodicalId":19419,"journal":{"name":"Oftalmologicheskii zhurnal","volume":"59 7","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140436935","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of vitreous angiopoietin-2 levels in rhegmatogenous retinal detachment on the macular microvascular bed 流变性视网膜脱离患者玻璃体血管生成素-2水平对黄斑微血管床的影响
Q4 Medicine Pub Date : 2024-02-23 DOI: 10.31288/oftalmolzh202413236
I. Bezkorovaina, A. Ivanchenko
Background: Our previous optical coherent tomography angiography (OCTA) study of rhegmatogenous retinal detachment (RRD) treatment has found an impaired retinal microvascular bed over a 12-month postoperative follow-up and warranted for the study of vitreous angiopoietin (Ang)-2 levels as a vascular destabilizing factor in patients treated for RRD. Purpose: To assess vitreous Ang-2 levels in patients with primary RRD and their association with OCTA-based changes in the macular microvascular bed in patients with RRD. Material and Methods: Eighty-seven patients with primary RRD were involved in the study and divided into two groups depending of the state of the macula: patients that underwent surgery for macular-on RRD (group 1) and those that underwent surgery for macular-off RRD (group 2). All patients had their vitreous samples taken and underwent subtotal posterior vitrectomy. Concentrations of Ang-2 in these samples were measured by an enzyme-linked immunosorbent assay (ELISA) kit (Human Angiopoietin-2 ELISA Kit, Thermo Fisher SCIENTIFIC, Rockford, IL, USA) in accordance with the manufacturer’s protocol. We assessed correlations of vitreous Ang-2 levels and OCTA-based parameters in patients. Results: At the preoperative vitreous Ang-2 level of 129.7 ± 51.99 pg/ml in group 1, there was a strong correlation of preoperative OCTA-based foveal avascular zone (FAZ) area, parafoveal deep capillary plexus density (PDCPD) and foveal deep capillary plexus density (FDCPD) with vitreous Ang-2 levels over the study period for group 1. At the preoperative vitreous Ang-2 level of 693.8 ± 634.7 pg/ml in group 2, there was a strong correlation of OCTA-based FAZ area, FDCPD, and PDCPD with vitreous Ang-2 levels at baseline and 12 months, and a moderate direct correlation of OCTA-based FAZ area, FDCPD, and PDCPD with vitreous Ang-2 levels at months 3 and 6. Conclusion: Vitreous Ang-2 levels were significantly lower in macula-on RRD eyes than in macula-off RRD eyes (129.7 ± 51.99 pg/ml versus 693.8 ± 634.7 pg/ml, p < 0.001). There was a strong direct correlation (p < 0.05) of Ang-2 with OCTA-based characteristics of the retinal microvascular bed (FAZ area, PDCPD and FDCPD) for both groups, which indirectly indicates the effect of the vascular destabilizing factor on the postoperative best-corrected visual acuity.
背景:我们之前对流变性视网膜脱离(RRD)治疗进行的光学相干断层血管造影(OCTA)研究发现,在术后 12 个月的随访中,视网膜微血管床受损,因此有必要对作为血管不稳定因素的玻璃体血管生成素(Ang)-2 水平进行研究。目的:评估原发性 RRD 患者玻璃体 Ang-2 水平及其与基于 OCTA 的 RRD 患者黄斑微血管床变化的关联。材料与方法:87名原发性RRD患者参与研究,并根据黄斑状态分为两组:接受黄斑上RRD手术的患者(第1组)和接受黄斑下RRD手术的患者(第2组)。所有患者都采集了玻璃体样本,并接受了后玻璃体次全切除术。这些样本中的 Ang-2 浓度是通过酶联免疫吸附试验(ELISA)试剂盒(人血管生成素-2 ELISA 试剂盒,Thermo Fisher SCIENTIFIC, Rockford, IL, USA)按照生产商的方案测定的。我们评估了患者玻璃体 Ang-2 水平与基于 OCTA 的参数之间的相关性。结果第1组患者术前玻璃体Ang-2水平为129.7 ± 51.99 pg/ml,在研究期间,第1组患者术前基于OCTA的视网膜无血管区(FAZ)面积、视网膜旁深毛细血管丛密度(PDCPD)和视网膜深毛细血管丛密度(FDCPD)与玻璃体Ang-2水平有很强的相关性。第 2 组术前玻璃体 Ang-2 水平为 693.8 ± 634.7 pg/ml,在基线和 12 个月时,基于 OCTA 的 FAZ 面积、FDCPD 和 PDCPD 与玻璃体 Ang-2 水平有很强的相关性,在第 3 个月和第 6 个月时,基于 OCTA 的 FAZ 面积、FDCPD 和 PDCPD 与玻璃体 Ang-2 水平有中等程度的直接相关性。结论黄斑上RRD眼的玻璃体Ang-2水平明显低于黄斑下RRD眼(129.7 ± 51.99 pg/ml对693.8 ± 634.7 pg/ml,P < 0.001)。两组患者的 Ang-2 与基于 OCTA 的视网膜微血管床特征(FAZ 面积、PDCPD 和 FDCPD)有很强的直接相关性(p < 0.05),这间接表明了血管不稳定因子对术后最佳矫正视力的影响。
{"title":"Effects of vitreous angiopoietin-2 levels in rhegmatogenous retinal detachment on the macular microvascular bed","authors":"I. Bezkorovaina, A. Ivanchenko","doi":"10.31288/oftalmolzh202413236","DOIUrl":"https://doi.org/10.31288/oftalmolzh202413236","url":null,"abstract":"Background: Our previous optical coherent tomography angiography (OCTA) study of rhegmatogenous retinal detachment (RRD) treatment has found an impaired retinal microvascular bed over a 12-month postoperative follow-up and warranted for the study of vitreous angiopoietin (Ang)-2 levels as a vascular destabilizing factor in patients treated for RRD. Purpose: To assess vitreous Ang-2 levels in patients with primary RRD and their association with OCTA-based changes in the macular microvascular bed in patients with RRD. Material and Methods: Eighty-seven patients with primary RRD were involved in the study and divided into two groups depending of the state of the macula: patients that underwent surgery for macular-on RRD (group 1) and those that underwent surgery for macular-off RRD (group 2). All patients had their vitreous samples taken and underwent subtotal posterior vitrectomy. Concentrations of Ang-2 in these samples were measured by an enzyme-linked immunosorbent assay (ELISA) kit (Human Angiopoietin-2 ELISA Kit, Thermo Fisher SCIENTIFIC, Rockford, IL, USA) in accordance with the manufacturer’s protocol. We assessed correlations of vitreous Ang-2 levels and OCTA-based parameters in patients. Results: At the preoperative vitreous Ang-2 level of 129.7 ± 51.99 pg/ml in group 1, there was a strong correlation of preoperative OCTA-based foveal avascular zone (FAZ) area, parafoveal deep capillary plexus density (PDCPD) and foveal deep capillary plexus density (FDCPD) with vitreous Ang-2 levels over the study period for group 1. At the preoperative vitreous Ang-2 level of 693.8 ± 634.7 pg/ml in group 2, there was a strong correlation of OCTA-based FAZ area, FDCPD, and PDCPD with vitreous Ang-2 levels at baseline and 12 months, and a moderate direct correlation of OCTA-based FAZ area, FDCPD, and PDCPD with vitreous Ang-2 levels at months 3 and 6. Conclusion: Vitreous Ang-2 levels were significantly lower in macula-on RRD eyes than in macula-off RRD eyes (129.7 ± 51.99 pg/ml versus 693.8 ± 634.7 pg/ml, p < 0.001). There was a strong direct correlation (p < 0.05) of Ang-2 with OCTA-based characteristics of the retinal microvascular bed (FAZ area, PDCPD and FDCPD) for both groups, which indirectly indicates the effect of the vascular destabilizing factor on the postoperative best-corrected visual acuity.","PeriodicalId":19419,"journal":{"name":"Oftalmologicheskii zhurnal","volume":"34 20","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140435262","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neutrophil activation marker CD15+ as a prognostic factor of ocular surface damage in type 2 diabetics 中性粒细胞活化标志物 CD15+ 是 2 型糖尿病患者眼表损伤的预后因素之一
Q4 Medicine Pub Date : 2024-02-23 DOI: 10.31288/oftalmolzh202411519
T. Zhmud, G. Drozhzhyna, L. Velychko
Purpose: To evaluate the prognostic value of the neutrophil activation marker CD15+ in ocular surface damage in type 2 diabetics. Material and Methods: This study was conducted from January 2021 to January 2021 at the Pirogov Vinnytsia Regional Clinical Hospital, the clinical site of the Medical University. A total of 60 type 2 diabetics (120 eyes) were enrolled, with an average age of 62.1 ± 5.24 years. Results: The prognostic value of the percentage expression of CD15+ in ocular surface damage in type 2 diabetics was for the first time evaluated. A rather high sensitivity of the percentage expression of CD15 (88.3%) allows using it as a parameter for screening for the presence of ocular surface damage in type 2 diabetics. Type 2 diabetics with a percentage of >27% of CD15+ cells had 10.52 times increased odds of ocular surface damage (95%CI, 4.34–25.50; p < 0.0001), and this value of the percentage of CD15+ cells can be used for the purpose of screening for ocular surface damage with a sensitivity of 88.3% (95% СІ, 77.8-94.2) and specificity of 63.3% (95% СІ, 50.7-74
目的:评估中性粒细胞活化标记物 CD15+ 在 2 型糖尿病患者眼表面损伤中的预后价值。材料与方法:本研究于 2021 年 1 月至 2021 年 1 月在医科大学临床基地皮罗戈夫-文尼察地区临床医院进行。共招募了 60 名 2 型糖尿病患者(120 只眼睛),平均年龄为 62.1 ± 5.24 岁。研究结果首次评估了 CD15+ 表达百分比在 2 型糖尿病患者眼表损伤中的预后价值。CD15 表达百分比的灵敏度相当高(88.3%),可将其作为筛查 2 型糖尿病患者眼表损伤的参数。CD15+ 细胞百分比大于 27% 的 2 型糖尿病患者发生眼表损伤的几率增加了 10.52 倍(95%CI,4.34-25.50;P <0.0001),CD15+ 细胞百分比的这一数值可用于筛查眼表损伤,其敏感性为 88.3%(95% СІ,77.8-94.2),特异性为 63.3%(95% СІ,50.7-74
{"title":"Neutrophil activation marker CD15+ as a prognostic factor of ocular surface damage in type 2 diabetics","authors":"T. Zhmud, G. Drozhzhyna, L. Velychko","doi":"10.31288/oftalmolzh202411519","DOIUrl":"https://doi.org/10.31288/oftalmolzh202411519","url":null,"abstract":"Purpose: To evaluate the prognostic value of the neutrophil activation marker CD15+ in ocular surface damage in type 2 diabetics. Material and Methods: This study was conducted from January 2021 to January 2021 at the Pirogov Vinnytsia Regional Clinical Hospital, the clinical site of the Medical University. A total of 60 type 2 diabetics (120 eyes) were enrolled, with an average age of 62.1 ± 5.24 years. Results: The prognostic value of the percentage expression of CD15+ in ocular surface damage in type 2 diabetics was for the first time evaluated. A rather high sensitivity of the percentage expression of CD15 (88.3%) allows using it as a parameter for screening for the presence of ocular surface damage in type 2 diabetics. Type 2 diabetics with a percentage of >27% of CD15+ cells had 10.52 times increased odds of ocular surface damage (95%CI, 4.34–25.50; p < 0.0001), and this value of the percentage of CD15+ cells can be used for the purpose of screening for ocular surface damage with a sensitivity of 88.3% (95% СІ, 77.8-94.2) and specificity of 63.3% (95% СІ, 50.7-74","PeriodicalId":19419,"journal":{"name":"Oftalmologicheskii zhurnal","volume":"23 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140435386","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cytologic features of the bulbar conjunctiva in patients with primary open-angle glaucoma-associated dry eye disease 原发性开角型青光眼相关干眼病患者球结膜的细胞学特征
Q4 Medicine Pub Date : 2023-09-04 DOI: 10.31288/oftalmolzh2023438
Т.М. Жмудь, Владислав Тетарчук, Ольга Олександрівна Андрушкова, Алла Василівна Демчук, Катерина Юріївна Гріжимальська, Світлана Петрівна Веретельник
Purpose: To examine the features of the bulbar conjunctiva in patients who developed dry-eye disease (DED) after drug treatment for primary open-angle glaucoma (POAG).Methods: Impression cytology was performed by applying twice a strip of cellulose acetate filter to the ocular surface to remove the superficial epithelial layers of the temporal bulbar conjunctiva. The strips were removed with a peeling motion in a few seconds, and the samples were immediately fixed in 95% ethyl alcohol, stained with hematoxylin and eosin, mounted on glass slides and coverslipped for light microscopy. Squamous metaplasia was graded according to Nelson’s grading system on the basis of cell morphology, staining and integrity as well as the nucleus-to-cytoplasm ratio. This study included a case group of 80 patients (mean age, 63.8 +- 6.7 years) with POAG-associated DED, with the group being divided into four subgroups. Subgroups 1 and 2 were composed of 40 patients each, with glaucoma duration of less or more than 5 years, respectively. Subgroups a and b were composed of 40 patients each, with a number of topical ocular hypotensive drugs used equal to one or at least two, respectively. The control group was composed of 20 apparently healthy volunteers (mean age, 67.9 +- 8.9 years). All patients underwent a routine eye examination.Results: All patients with glaucoma had symptoms of DED with Ocular Surface Disease Index (OSDI) scores of at least 15. In subgroup 1, 60% had Nelson’s grade 1 and 40%, Nelson’s grade 2 squamous metaplasia. In subgroup 2, 10% had Nelson’s grade 1; 60%, Nelson’s grade 2 and 30%, Nelson’s grade 3 squamous metaplasia. In subgroup a, 20% had Nelson’s grade 1; 60%, Nelson’s grade 2 and 30%, Nelson’s grade 3 squamous metaplasia. In subgroup b, 10% had Nelson’s grade 1; 60%, Nelson’s grade 2 and 30%, Nelson’s grade 3 squamous metaplasia.Conclusion: Changes in the bulbar conjunctival epithelium corresponded to Nelson’s grade 2 or 3 squamous metaplasia in 80% of patients who developed DED after drug treatment for POAG. The severity of squamous metaplasia correlated with the duration of glaucoma and, consequently, longer use of hypotensive eye drops (r1 = 0.15, p1 = 0.02, p2 = 0.01). Findings of the current study and international guidelines argue for the use of the medications containing no preservatives or potentially toxic components in long-term therapy against glaucoma.
目的:探讨原发性开角型青光眼(POAG)药物治疗后发生干眼病(DED)患者的球结膜特征。方法:印迹细胞学通过在眼表应用两次醋酸纤维素过滤器去除颞球结膜的浅表上皮进行。在几秒钟内用剥离动作去除条带,并立即将样品固定在95%乙醇中,用苏木精和伊红染色,安装在玻片上并盖上盖进行光学显微镜检查。根据细胞形态、染色、完整性及核质比,按照Nelson分级系统对鳞状化生进行分级。本研究纳入80例poag相关DED患者(平均年龄63.8±6.7岁),并将其分为4个亚组。亚组1和亚组2各40例患者,青光眼持续时间分别小于或大于5年。亚组a和b各40例患者,分别使用一种或至少两种局部降压药物。对照组由20名表面健康的志愿者组成(平均年龄67.9±8.9岁)。所有患者都进行了常规眼科检查。结果:所有青光眼患者均有DED症状,且眼表疾病指数(OSDI)评分至少为15分。在第1亚组中,60%的人患有纳尔逊1级鳞状皮化生,40%的人患有纳尔逊2级鳞状皮化生。在第二组中,10%的人患有纳尔逊1级;60%, Nelson氏2级30%,Nelson氏3级鳞状化生。在a分组中,20%的人达到Nelson的1级;60%, Nelson氏2级30%,Nelson氏3级鳞状化生。在b组中,10%的人患有纳尔逊1级;60%, Nelson氏2级30%,Nelson氏3级鳞状化生。结论:在80%的POAG药物治疗后发生DED的患者中,球结膜上皮的变化符合Nelson的2级或3级鳞状化生。鳞状化生的严重程度与青光眼的持续时间相关,因此,使用降压眼药水的时间越长(r1 = 0.15, p1 = 0.02, p2 = 0.01)。目前的研究结果和国际指南主张在青光眼的长期治疗中使用不含防腐剂或潜在毒性成分的药物。
{"title":"Cytologic features of the bulbar conjunctiva in patients with primary open-angle glaucoma-associated dry eye disease","authors":"Т.М. Жмудь, Владислав Тетарчук, Ольга Олександрівна Андрушкова, Алла Василівна Демчук, Катерина Юріївна Гріжимальська, Світлана Петрівна Веретельник","doi":"10.31288/oftalmolzh2023438","DOIUrl":"https://doi.org/10.31288/oftalmolzh2023438","url":null,"abstract":"Purpose: To examine the features of the bulbar conjunctiva in patients who developed dry-eye disease (DED) after drug treatment for primary open-angle glaucoma (POAG).\u0000\u0000Methods: Impression cytology was performed by applying twice a strip of cellulose acetate filter to the ocular surface to remove the superficial epithelial layers of the temporal bulbar conjunctiva. The strips were removed with a peeling motion in a few seconds, and the samples were immediately fixed in 95% ethyl alcohol, stained with hematoxylin and eosin, mounted on glass slides and coverslipped for light microscopy. Squamous metaplasia was graded according to Nelson’s grading system on the basis of cell morphology, staining and integrity as well as the nucleus-to-cytoplasm ratio. This study included a case group of 80 patients (mean age, 63.8 +- 6.7 years) with POAG-associated DED, with the group being divided into four subgroups. Subgroups 1 and 2 were composed of 40 patients each, with glaucoma duration of less or more than 5 years, respectively. Subgroups a and b were composed of 40 patients each, with a number of topical ocular hypotensive drugs used equal to one or at least two, respectively. The control group was composed of 20 apparently healthy volunteers (mean age, 67.9 +- 8.9 years). All patients underwent a routine eye examination.\u0000\u0000Results: All patients with glaucoma had symptoms of DED with Ocular Surface Disease Index (OSDI) scores of at least 15. In subgroup 1, 60% had Nelson’s grade 1 and 40%, Nelson’s grade 2 squamous metaplasia. In subgroup 2, 10% had Nelson’s grade 1; 60%, Nelson’s grade 2 and 30%, Nelson’s grade 3 squamous metaplasia. In subgroup a, 20% had Nelson’s grade 1; 60%, Nelson’s grade 2 and 30%, Nelson’s grade 3 squamous metaplasia. In subgroup b, 10% had Nelson’s grade 1; 60%, Nelson’s grade 2 and 30%, Nelson’s grade 3 squamous metaplasia.\u0000\u0000Conclusion: Changes in the bulbar conjunctival epithelium corresponded to Nelson’s grade 2 or 3 squamous metaplasia in 80% of patients who developed DED after drug treatment for POAG. The severity of squamous metaplasia correlated with the duration of glaucoma and, consequently, longer use of hypotensive eye drops (r1 = 0.15, p1 = 0.02, p2 = 0.01). Findings of the current study and international guidelines argue for the use of the medications containing no preservatives or potentially toxic components in long-term therapy against glaucoma.","PeriodicalId":19419,"journal":{"name":"Oftalmologicheskii zhurnal","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48510714","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retinal energy state in rats with experimental diabetes and axial myopia 实验性糖尿病和轴性近视大鼠视网膜能量状态的研究
Q4 Medicine Pub Date : 2023-09-04 DOI: 10.31288/oftalmolzh202346166
І.М. Михейцева, Ахмед Амаієд, Сергій Коломійчук
Background: Elucidating the pathogenesis of diabetic retinopathy (DR) for further development of methods of treatment and prevention of the disease is an important medical and social task for ophthalmologists. The development of DR in the presence of myopia has some special features. In the presence of myopia, the diabetic complications in the retina are less severe than in emmetropia. The mechanisms of this paradoxical impact of eye myopization on the severity of these complications are, however, still unknown.Purpose: To examine the state of retinal energy metabolism based on evaluation of biochemical markers of mitochondrial function (lactate, pyruvate, adenosine triphosphate (ATP) and adenosine diphosphate (ADP) levels and succinate dehydrogenase activity) in rats with streptozotocin (STZ)-induced diabetes that developed in the presence of axial myopia, compared to rats with diabetes alone and those with myopia alone.Material and Methods: High axial myopia was produced in two-week animals by surgically fusing the eyelids of both eyes and maintaining these animals under conditions of reduced illumination for two weeks. A 15 mg/kg intraperitoneal streptozotocin injection for 5 days was used for inducing diabetes mellitus in rats with induced axial myopia and intact rats. Animals in the control group were maintained under conditions of natural illumination. In two months, all rats were euthanized under anesthesia, and their eyes were enucleated. ATP, ADP, lactate, and pyruvate levels were measured in blood and retinal specimens and ATP/ADP ratio and lactate/pyruvate ratio were determined. Succinate dehydrogenase activity was determined in isolated retinal mitochondria. For statistical analysis of biochemical results, Student’s t-test was conducted (Statistica software).Results: Rats with diabetes alone exhibited lower retinal and plasma energy metabolism characteristics (ATP, ADP, and succinate dehydrogenase activity), and developed retinal hypoxia, with retinal lactate and pyruvate levels being 1.838-fold and 1.455-fold higher, respectively, and their ratio, 26.5% higher, compared to controls. In animals with STZ-induced diabetes in the presence of axial hypoxia, retinal lactate and pyruvate levels were 20.2% and 15.5% lower, respectively, and their ratio was lower (36.5 versus 38.7), compared to rats with diabetes alone, indicating lower hypoxia in the setting of eye myopization. In addition, in rats with diabetes in the presence of axial hypoxia, plasma and retinal ATP levels were 21.8% and 21.2% higher, respectively, and retinal succinate dehydrogenase activity, 20.8% higher, compared to rats with diabetes alone.Conclusion: In experimental diabetes, an increase in the axial length of the eye (i.e., eye myopization) is accompanied by activation of energy processes and the development of hypoxia adaptation in retinal cells.
背景:阐明糖尿病视网膜病变(DR)的发病机制,以进一步开发该疾病的治疗和预防方法,是眼科医生的一项重要医学和社会任务。在近视的情况下DR的发展有一些特殊的特点。在近视的情况下,糖尿病视网膜并发症的严重程度低于正视眼。然而,近视化对这些并发症严重程度的这种矛盾影响的机制仍然未知。目的:通过评估链脲佐菌素(STZ)诱导的糖尿病大鼠线粒体功能的生化标志物(乳酸、丙酮酸、三磷酸腺苷(ATP)和二磷酸腺苷(ADP)水平以及琥珀酸脱氢酶活性),检测视网膜能量代谢的状态,与单独患有糖尿病的大鼠和单独患有近视的大鼠相比。材料和方法:通过手术融合双眼皮并在光照减少的条件下维持两周,在两周的动物中产生高度轴性近视。15 mg/kg腹腔注射链脲佐菌素5天用于诱导轴性近视大鼠和完整大鼠的糖尿病。对照组动物在自然光照条件下饲养。两个月后,所有大鼠在麻醉下实施安乐死,并摘除眼睛。测量血液和视网膜标本中的ATP、ADP、乳酸和丙酮酸水平,并测定ATP/ADP比率和乳酸/丙酮酸比率。在分离的视网膜线粒体中测定琥珀酸脱氢酶活性。为了对生化结果进行统计分析,进行了Student t检验(Statistica软件)。结果:单独患有糖尿病的大鼠表现出较低的视网膜和血浆能量代谢特征(ATP、ADP和琥珀酸脱氢酶活性),并出现视网膜缺氧,视网膜乳酸和丙酮酸水平分别高1.838倍和1.455倍,与对照组相比高26.5%。在存在轴性缺氧的STZ诱导的糖尿病动物中,与单独患有糖尿病的大鼠相比,视网膜乳酸盐和丙酮酸盐水平分别降低20.2%和15.5%,其比率更低(36.5对38.7),这表明在眼睛近视的情况下缺氧程度较低。此外,在存在轴向缺氧的糖尿病大鼠中,与单独患有糖尿病的大鼠相比,血浆和视网膜ATP水平分别高21.8%和21.2%,视网膜琥珀酸脱氢酶活性高20.8%。结论:在实验性糖尿病中,眼轴长度的增加(即近视)伴随着能量过程的激活和视网膜细胞缺氧适应的发展。
{"title":"Retinal energy state in rats with experimental diabetes and axial myopia","authors":"І.М. Михейцева, Ахмед Амаієд, Сергій Коломійчук","doi":"10.31288/oftalmolzh202346166","DOIUrl":"https://doi.org/10.31288/oftalmolzh202346166","url":null,"abstract":"Background: Elucidating the pathogenesis of diabetic retinopathy (DR) for further development of methods of treatment and prevention of the disease is an important medical and social task for ophthalmologists. The development of DR in the presence of myopia has some special features. In the presence of myopia, the diabetic complications in the retina are less severe than in emmetropia. The mechanisms of this paradoxical impact of eye myopization on the severity of these complications are, however, still unknown.\u0000\u0000Purpose: To examine the state of retinal energy metabolism based on evaluation of biochemical markers of mitochondrial function (lactate, pyruvate, adenosine triphosphate (ATP) and adenosine diphosphate (ADP) levels and succinate dehydrogenase activity) in rats with streptozotocin (STZ)-induced diabetes that developed in the presence of axial myopia, compared to rats with diabetes alone and those with myopia alone.\u0000\u0000Material and Methods: High axial myopia was produced in two-week animals by surgically fusing the eyelids of both eyes and maintaining these animals under conditions of reduced illumination for two weeks. A 15 mg/kg intraperitoneal streptozotocin injection for 5 days was used for inducing diabetes mellitus in rats with induced axial myopia and intact rats. Animals in the control group were maintained under conditions of natural illumination. In two months, all rats were euthanized under anesthesia, and their eyes were enucleated. ATP, ADP, lactate, and pyruvate levels were measured in blood and retinal specimens and ATP/ADP ratio and lactate/pyruvate ratio were determined. Succinate dehydrogenase activity was determined in isolated retinal mitochondria. For statistical analysis of biochemical results, Student’s t-test was conducted (Statistica software).\u0000\u0000Results: Rats with diabetes alone exhibited lower retinal and plasma energy metabolism characteristics (ATP, ADP, and succinate dehydrogenase activity), and developed retinal hypoxia, with retinal lactate and pyruvate levels being 1.838-fold and 1.455-fold higher, respectively, and their ratio, 26.5% higher, compared to controls. In animals with STZ-induced diabetes in the presence of axial hypoxia, retinal lactate and pyruvate levels were 20.2% and 15.5% lower, respectively, and their ratio was lower (36.5 versus 38.7), compared to rats with diabetes alone, indicating lower hypoxia in the setting of eye myopization. In addition, in rats with diabetes in the presence of axial hypoxia, plasma and retinal ATP levels were 21.8% and 21.2% higher, respectively, and retinal succinate dehydrogenase activity, 20.8% higher, compared to rats with diabetes alone.\u0000\u0000Conclusion: In experimental diabetes, an increase in the axial length of the eye (i.e., eye myopization) is accompanied by activation of energy processes and the development of hypoxia adaptation in retinal cells.","PeriodicalId":19419,"journal":{"name":"Oftalmologicheskii zhurnal","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45153253","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Oftalmologicheskii zhurnal
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1